Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roxadustat for erythropoietin hyporesponsive renal anemia in hemodialysis patients
ChiCTR2000031645Phase 4Not yet recruiting
- Sponsor
- Ya'an People's Hospital
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of roxadustat in anemia of chronic kidney disease, sponsored by Ya'an People's Hospital. Primary endpoint: hemoglobin. Planned start May 2020; status: not yet recruiting.
02
Drugs
roxadustat
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on ChiCTR2000031645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031645.